Biomarkers to define the treatment end-point for pulmonary exacerbations in cystic fibrosis
Advances in our understanding of early cystic fibrosis lung disease led by the Australian Early Surveillance Team for Cystic Fibrosis (AREST CF) have also indicated the potential utility of a number of biomarkers for monitoring disease severity.
PREDICT CF: Assessing the role of lung clearance index in predicting disease progression in children with cystic fibrosis
There is increasing evidence that the assessment of ventilation distribution using the multiple breath washout (MBW) technique is sensitive to changes in disease status of children with cystic fibrosis.